FDA Investigator Damaris Y Hernandez

Damaris Y Hernandez has conducted inspections on 15 sites in 3 countries as of 08 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
15
Last Inspection Date:
08 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100001632
Countries of Inspections:
United States of America, China, Brazil
FDA Investigators that have inspected at least one site in common with Damaris Y Hernandez:
Ademola O Daramola, Alan L Truong, Andrea A Branche, Andrew A Hoopes, Anthony R Bucks, Aqualia L Nelson, Ariel Cruz Figueroa, Ashley A Mutawakkil, Bill Tacket, Jr, Binh T Nguyen, Brandon P Thompson, Brenda G Stewart Munoz, Brett R Havranek, Brittany D Terhar, Camerson E Moore, Carl A Huffman, III, Cathleen A Castellaw, CDR Ileana Barreto Pettit, Chilton L Ng, Christine A Harman, PhD, Christopher D Rush, Cody D Rickman, Daniel J Lahar, Daniel S Fam, Darla J Christopher, Daryl A Dewoskin, David J Eide, Deborah A Greco, Dennis Cantellops Paite, Dillard H Woody, Jr, Donald L Myers, Dorothy P Kramer, Eric M Mueller, PharmD, Eric M Padgett, Ernest A Clausnitzer, Felix Maldonado, Gabriel E Muniz, Gene R Gunn, German Rivera, Gwyn G Dickinson, Hector A Carrero, Helen Y Saccone, Iraida Ortiz, Israel Juarbe, Jacqueline Mdiaz Albertini, James I Giefer, Jamie M Bumpas, Janet B Abt, Jason P Aun, Jazmine N Still, Jennifer L Huntington, Jennifer Lalama, Jennifer O Dowdy, Jessica L Pressley, Joann Walters Salvatierra, Joanne E King, José E Meléndez, Jose Velez, Joseph R Lambert, Justin H Price, Karen M Rodriguez, Karissa J Mccaw, Kelly K Nachtigal, Ken L Bowers, Kevin D Kallander, Kunapuli T Madhusudhan, Lewis K Antwi, Lisa R Jennings, Lisa R Whitt, Liza L Quiles, LT Daveta L Bailey, Luis A Dasta, Lundy H Patrick, Mabany Lizardi, Margaret A Smithers, Margaret M Annes, Marian E Ramirez, Marie F Morin, Matthew M Schuckmann, Matthew R Sleeter, Michael L Chasey, Michele L Obert, Michele Perry Williams, Miguel A Martinez Perez, Mizanne E Lewis, Monica M Mcclure, Nancy G Schmidt, Nicole E Knowlton, Noreen Muñiz, Omotunde O Osunsanmi, Paraluman S Leonin, Patrice S Hall, Paul L Figarole, Jr, Paula A Trost, Pauline N Logan, Rafael Nevarez Nieves, Ralph H Vocque, Ramon A Hernandez, Richard K Vogel, Richard L Rutherford, Rita K Kabaso, Robert J Ham, Rozelle G Smith, Salvatore N Randazzo, Sandy J Ziegler, Sarah E Rhoades, Sarah L Fredric, Satheesh Thomas, Scott A Golladay, Scott R Nichols, PhD, Scott T Ballard, Shafiq S Ahadi, Sherrie L Krolczyk, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Sonia M Monges, Stephanie C Milan, Stephen D Brown, Stephen J Koniers, Stephen L Beekman, Steven A Brettler, Steven D Kehoe, Steven P Donald, Susan M Jackson, Susanna E Ford, Suzanne N Vallez, Tara L Breckenridge, Tara L Greene, Teresa I Navas, Uduak M Inokon, Walden H Lee, Walsworth, Zi Qiang Gu

Damaris Y Hernandez's Documents

Publish Date Document Type Title
October, 2022 FDA 483 Chemco Corporation - Form 483, 2022-10-31
March, 2024 FDA 483 NATURAL TECHNOLOGY, LLC - Form 483, 2024-03-01
January, 2024 FDA 483 The Richline Group, Inc. - Form 483, 2024-01-12
June, 2022 EIR QuVa Pharma, Inc. - EIR, 2022-06-16
September, 2022 FDA 483 PAI Holdings, LLC, dba Pharmaceutical Associates, Inc - Form 483, 2022-09-02
October, 2023 FDA 483 Ultrum Labs, LLC - Form 483, 2023-10-16
June, 2022 FDA 483 QuVa Pharma, Inc. - Form 483, 2022-06-16
July, 2022 FDA 483 Tarmac Products, Inc. - Form 483, 2022-07-22
June, 2023 FDA 483 Hospira, Inc. - Form 483, 2023-06-30
June, 2022 FDA 483 Response QuVa Pharma, Inc. - Form 483R, 2022-07-08
August, 2023 FDA 483 INOVAT Industria Farmaceutica LTDA. - Form 483, 2023-08-09
March, 2022 FDA 483 Klocke of America, Inc. - Form 483, 2022-03-30
September, 2024 FDA 483 Salon Technologies International, Inc - Form 483, 2024-09-20
March, 2024 EIR Huzhou Zhanwang Pharmaceutical Co., Ltd. - EIR, 2024-12-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more